RecruitingNot applicableNCT05219110

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Studying Hemolytic uremic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Calgary
Principal Investigator
Stephen Freedman, MDCM
University of Calgary
Intervention
Infusion of 200% maintenance fluids as balanced crystalloid IV solution(other)
Enrollment
1040 enrolled
Eligibility
21 years · All sexes
Timeline
20222027

Study locations (26)

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID) · Children's Hospital Medical Center, Cincinnati · Washington University School of Medicine · University of Utah · Seattle Children's Hospital · University of Colorado, Denver · Emory University · University of California, Davis · Baylor College of Medicine · Indiana University School of Medicine · University of Alabama at Birmingham · Arkansas Children's Hospital Research Institute · Children's National Research Institute · Children's Hospitals and Clinics of Minnesota · Medical University of South Carolina · University of Louisville · University of Oklahoma · Oregon Health and Science University · University of California, San Diego · McMaster University · The Hospital for Sick Children · University of Alberta · University of Kentucky · Case Western Reserve University · Nationwide Children's Hospital · Vanderbilt University Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05219110 on ClinicalTrials.gov

Other trials for Hemolytic uremic syndrome

Additional recruiting or active studies for the same condition.

See all trials for Hemolytic uremic syndrome

← Back to all trials